| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Roberts M Scot is a Chief Scientific Officer at ALT. Recent filings cover 1 purchase and 4 sales. Those positions are worth an estimated $274K at current prices.
Our model assigns Roberts M Scot a middling insider score of 67/100, based on 4 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +69.9%.
Roberts M Scot's largest disclosed position is in ALT as Chief Scientific Officer, worth about $274K. The recent filings there lean toward selling, a net 79,529 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 5, 2022 | ALT Altimmune, Inc. | Chief Scientific Officer | Sale+OE | 37,164 | $12.00 | $445,968.00 | -81.7% | +5.2% | -72.1% | |
| Jun 29, 2022 | ALT Altimmune, Inc. | Chief Scientific Officer | Sale+OE | 5,462 | $12.00 | $65,546.18 | -23.6% | +3.9% | -70.3% | |
| Jun 27, 2022 | ALT Altimmune, Inc. | Chief Scientific Officer | Sale+OE | 37,352 | $12.00 | $448,253.88 | -67.8% | -0.2% | -68.6% | |
| Jun 6, 2017 | ALT Altimmune, Inc. | Chief Scientific Officer | Buy | 449 | $4.42 | $1,984.58 | New | - | - |